Skip to main content
← All guides

Advanced Research Projects Agency for Health (ARPA-H) — CFDA 93.384

$1.75 billion in federal obligations is indexed on USAspending.gov for the Advanced Research Projects Agency for Health (ARPA-H) (CFDA 93.384). The listing carries 145 awards, 109 recipients, and a 31-state geographic count. Those dollars are assistance obligations, not Treasury outlays and not a count of clinical trials, prototypes, or diseases. One hundred nine recipients against 145 awards is a concentrated R&D file: large project awards, not a 50-state formula roster.

Key figures

  • CFDA 93.384 shows $1.75 billion in USAspending obligations for ARPA-H.
  • The listing covers 145 awards and 109 recipients.
  • Awards are coded to 31 states in the USAspending geographic count.
  • Totals are obligations, not outlays or trial counts.

ARPA-H obligations at $1.75 billion

USAspending.gov records $1,746,996,454 in obligations under CFDA 93.384. One hundred forty-five awards produce that stock. A simple average is about $12.05 million per award — larger than a typical investigator R01 and consistent with high-risk project awards. That average is a quotient of two packet totals, not a typical lab budget or a per-trial cost.

The assistance-listing title is ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H). CFDA 93.384 is the identifier. Other HHS research listings tagged under different CFDA numbers are not mixed into the $1.75 billion. Combining those codes would invent a combined biomedical-R&D total this packet does not contain.

109 recipients across 31 states

One hundred nine recipients share 145 awards, or about 1.3 award records per recipient on average. Splitting $1.75 billion evenly would assign about $16.03 million per recipient. That pattern is close to one large award per named organization, which fits a new-agency project portfolio rather than thousands of small grants. The packet does not list the 109. Recipient count is the organizational headcount, not a census of investigators or patients.

Thirty-one states in the geographic count leave a visibly incomplete map. ARPA-H dollars follow where performers are coded, not population. Place-of-performance amounts are on the program table.

One hundred forty-five awards on 109 recipients in 31 states is a concentrated R&D portfolio, not a 50-state formula. About $12.05 million per award is project-scale, larger than a typical investigator grant. The $1,746,996,454 obligation stock is not a trial registry, not a patent file, and not an NIH institute rollup. ARPA-E (a different agency listing) is a separate CFDA. Quote 145 as assistance rows and 109 as named organizations. Outlays remain unreported on this packet.

Award count is not a project-milestone count

Among HHS research listings, 93.384 is a thin file: 145 rows against 109 recipients. Multi-year project rows and amendments can inflate award count relative to unique performers. Award count is therefore a weak proxy for “number of breakthroughs.” Recipients (109) tell you how many named organizations sit on the extract; awards (145) tell you how many assistance rows were stored.

The packet does not report trials, patents, or disease areas. Citing 145 as treatments would be a unit error. Keep the units straight: dollars, awards, recipients, states.

Obligations versus payment outlays

The $1.75 billion is an obligation total from USAspending.gov. Outlays — cash paid against ARPA-H awards — are not in the packet. A performer can show a large obligation stock while a draw follows a later milestone. Deobligations and upward adjustments both move the total. A remaining-balance question is an outlay question this extract does not answer.

Use CFDA 93.384 to size this ARPA-H listing in the assistance file. Do not use it as an NIH institute, BARDA, or ARPA-E dashboard. Those series live on other codes. This page reports the obligation book tagged 93.384.

What the 93.384 tables omit

The ARPA-H hub lists award-backed obligations from USAspending.gov. It is not a trial registry, not a patent file, and not a disease-burden survey. Series that never appear as assistance awards will not show up in the $1,746,996,454. That omission is definitional rather than a gap in the 145 award rows.

Place-of-performance on 31 states is a coding field. Read the program page before treating those cells as equal shares. Recipient dollars, if shown on the hub, are still obligation amounts, not cash already spent on research.

Where the 93.384 table lives

The program page overlays these four facts. The all-programs index ranks 93.384 among other assistance listings. Agency pages show awarding-agency rollups that may include this CFDA among other HHS listings. For 93.384 only, start on the program page.

CFDA 93.384’s 145 awards spread $1,746,996,454 across 109 recipients and 31 states. Quote award count as a record count, recipient count as the organizational headcount, and dollars as obligations from USAspending.gov. About $12.05 million per award is the size story on this listing. Outlays remain a separate column. Source: USAspending.gov assistance awards.

Questions

How much is obligated for ARPA-H?
USAspending.gov records $1,746,996,454 in obligations for CFDA 93.384. SpendingVault indexes 145 awards, 109 recipients, and 31 states. The figure is an obligation sum from assistance awards, not an outlay and not a trial count. CFDA 93.384’s $1.75 billion is the USAspending obligation stock.
How many awards does CFDA 93.384 carry?
The listing shows 145 awards against 109 recipients, or about 1.3 award records per recipient. A simple average is about $12.05 million per award. Award count is not a disease or patent count. Recipient dollars are on the program page.
How many organizations receive 93.384 awards?
The extract lists 109 recipients. Those are organizational recipients on assistance awards tagged 93.384. Geographic coding covers 31 states. The packet does not name the 109 or publish trial data. Recipient count is the organizational headcount. USAspending.gov indexes those rows as assistance obligations, not outlays.
Is $1.75 billion already paid to ARPA-H performers?
Not necessarily. Obligations are commitments. Outlays are payments. CFDA 93.384’s indexed total is the obligation stock from USAspending.gov. This page does not report cash drawn, remaining balances, or research outputs. The $1.75 billion on 145 awards is the obligation figure.

CFDA/Assistance Listing numbers from USAspending assistance awards on SpendingVault.